Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5276478
Max Phase: Preclinical
Molecular Formula: C33H46FNO6
Molecular Weight: 571.73
Associated Items:
ID: ALA5276478
Max Phase: Preclinical
Molecular Formula: C33H46FNO6
Molecular Weight: 571.73
Associated Items:
Canonical SMILES: C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](OC(=O)c4ccc(F)cc4)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Standard InChI: InChI=1S/C33H46FNO6/c1-19(4-11-28(37)35-18-29(38)39)24-9-10-25-30-26(13-15-33(24,25)3)32(2)14-12-23(36)16-21(32)17-27(30)41-31(40)20-5-7-22(34)8-6-20/h5-8,19,21,23-27,30,36H,4,9-18H2,1-3H3,(H,35,37)(H,38,39)/t19-,21+,23-,24-,25+,26+,27+,30+,32+,33-/m1/s1
Standard InChI Key: PXYKVZQMEAUZRC-SHABMYLESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 571.73 | Molecular Weight (Monoisotopic): 571.3309 | AlogP: 5.60 | #Rotatable Bonds: 8 |
Polar Surface Area: 112.93 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.77 | CX Basic pKa: | CX LogP: 5.25 | CX LogD: 1.97 |
Aromatic Rings: 1 | Heavy Atoms: 41 | QED Weighted: 0.35 | Np Likeness Score: 1.28 |
1. Singla P, Salunke DB.. (2020) Recent advances in steroid amino acid conjugates: Old scaffolds with new dimensions., 187 [PMID:31830636] [10.1016/j.ejmech.2019.111909] |
Source(1):